Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose

Mary C. Birmingham, Ross Guarino, Allen Heller, John H. Wilton, Anita Shah, Linda Hejmanowski, David E. Nix, Jerome J. Schentag

Research output: Contribution to journalArticle

26 Scopus citations

Abstract

Intravenous ciprofloxacin is frequently prescribed for the treatment of infections due to nosocomially acquired Gram-negative organisms, including those originating in the respiratory tract. In this study, the concentrations of ciprofloxacin in serum and lung tissue were determined by HPLC in patients undergoing lung surgery. A total of 22 patients scheduled for lung surgery received a single 400 mg iv dose of ciprofloxacin administered as a 1 h infusion. A specimen of healthy lung tissue was obtained from resected lung from 18 of the patients for analysis of ciprofloxacin concentration during the following time intervals after infusion (one sample/patient): 0-2, 2-4, 4-8 and 8-12 h. Corresponding mean serum and tissue concentrations were 2.37 mg/L and 3.84 mg/kg (0-2 h), 1.18 mg/L and 1.92 mg/kg (2-4 h), 0.69 mg/L and 1.77 mg/kg (4-8 h), and 0.13 mg/L and 0.67 mg/kg (8-12 h). Ciprofloxacin distributed rapidly to lung tissue, as seen by the high concentrations in the lung tissue as early as 2 h after infusion. Concentrations in lung tissue were generally higher than those in serum (tissue:serum ratios ranged from 1.7 to 7.1). The mean tissue concentrations found in this study remained above the MIC for most susceptible organisms.

Original languageEnglish (US)
Pages (from-to)43-48
Number of pages6
JournalJournal of Antimicrobial Chemotherapy
Volume43
Issue numberSUPPL. A
StatePublished - Mar 22 1999
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Birmingham, M. C., Guarino, R., Heller, A., Wilton, J. H., Shah, A., Hejmanowski, L., Nix, D. E., & Schentag, J. J. (1999). Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose. Journal of Antimicrobial Chemotherapy, 43(SUPPL. A), 43-48.